KorinMi has secured a Rs 10 crore investment from the Lotus Herbals Innovation Fund. The funding will accelerate its expansion in India’s fast-growing aesthetic skincare market. The Gurugram-based startup plans to scale its Korean-style dermatology clinic model across Mumbai, Bengaluru, and Hyderabad. The move marks its shift from a single-city presence to a national footprint.
Blending clinical care and D2C skincare
The startup combines clinical dermatology services with direct-to-consumer skincare products. It targets India’s premium beauty and wellness segment, which continues to expand rapidly. KorinMi integrates in-clinic treatments with curated skincare routines inspired by Korean dermatology practices. This hybrid model appeals to consumers seeking both medical-grade and lifestyle skincare solutions.
Expansion driven by fresh capital
The Rs 10 crore investment will support infrastructure expansion and operational scaling. The company plans to open new clinics in high-demand metro cities. It will also strengthen supply chain systems for imported Korean equipment and formulations. The business relies heavily on South Korean imports to maintain consistent treatment quality and product standards.
Operational challenges in a global supply model
The import-heavy structure creates exposure to currency fluctuations and cost pressures. Regulatory requirements for medical aesthetics in India add further compliance complexity. The company must also manage inventory efficiently to prevent cash flow strain. These challenges intensify as it enters larger and more competitive urban markets.
Competing in a fragmented skincare market
India’s aesthetic skincare sector remains highly fragmented across chains, clinics, and independent providers. KorinMi positions itself in the premium segment, where customers expect advanced technology and high service standards. It uses imported diagnostic tools such as skin analysis systems that require trained professionals. Talent acquisition and training remain critical priorities for scaling operations.
The D2C skincare market adds further competitive pressure. Large e-commerce platforms continue to discount beauty products aggressively. This limits pricing power for premium brands that depend on differentiation. KorinMi must balance clinic revenue with product sales while protecting its brand positioning. Marketing efficiency will play a key role in customer acquisition and retention.
Outlook and growth strategy
Despite challenges, investor confidence reflects strong demand for advanced skincare solutions in India. KorinMi’s leadership aims to institutionalise operations and build a scalable clinic network. The company now shifts focus from early growth to sustainable profitability. Execution across multiple cities will determine its long-term success in a competitive wellness market.